Special Issue "Natural Products for the Treatment of Breast Cancer"
Deadline for manuscript submissions: 30 November 2023 | Viewed by 10620
Interests: novel therapeutics in cancer treatment; breast cancer; drug development
Special Issues, Collections and Topics in MDPI journals
Nature has always been a key inspiration in drug development, in particular anti-cancer drug development. Despite advances in cancer treatment procedures including radiotherapy and surgery, medicinal-mediated treatment, most importantly chemotherapy, is still a mainstay of treatment for most tumours. Chemotherapy is, however, accompanied by side effects. Tumour resistance and adverse reactions limit the patients' compliance and tumour response to treatment. Therefore, the search to find the best treatment options continues.
Breast cancer is the most prevalent form of cancer worldwide. This Special Issue aims to integrate recent improvements in drug development for breast cancer with an effort to expand the knowledge on a wide range of topics in this field. I would like to sincerely invite you to contribute to this Special Issue with your research articles and reviews, which include but are not limited to natural medicines targeting the treatment of early or advanced breast cancer with an emphasis on treatments aimed to inhibit and treat metastasis, especially brain metastasis, nanomedicines, single or combination treatments, targeted treatments and novel targeted formulations, animal models, and clinical outcomes.
Dr. Maryam Nakhjavani
Dr. Vy Broadbridge
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- natural medicine
- breast cancer
- drug development
- herbal medicine
- plant-derived medicine
- marine-derived medicine
- traditional herbal medicine